MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$2,230K
(45.25%↑ Y/Y)
Emrosi
$6,252K
(202.03%↑ Y/Y)
Qbrexza
$5,028K
(-2.58%↓ Y/Y)
Accutane
$3,314K
(-9.33%↓ Y/Y)
Foam Franchise
Products Amzeeq Zilxi
$1,050K
Other Legacy
$277K
(-61.90%↓ Y/Y)
Loss before income
taxes
-$2,230K
(45.25%↑ Y/Y)
Product revenue, net
$15,921K
(21.17%↑ Y/Y)
Other revenue
$40K
Loss from operations
-$1,492K
(55.11%↑ Y/Y)
Total other expense
-$738K
(1.47%↑ Y/Y)
Total revenue
$15,961K
(21.48%↑ Y/Y)
Interest income
$157K
(5.37%↑ Y/Y)
Total operating
expenses
$17,453K
(6.01%↑ Y/Y)
Interest expense
$892K
(0.11%↑ Y/Y)
Foreign exchange
transaction losses
-$3K
(57.14%↑ Y/Y)
Selling, general and
administrative
$10,109K
(-4.35%↓ Y/Y)
Cost of goods sold -
(excluding amortization of...
$6,218K
(29.81%↑ Y/Y)
Amortization of acquired
intangible assets
$1,126K
(5.73%↑ Y/Y)
Back
Back
Income Statement
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)
source: myfinsight.com